UroGen Announces Completion of Enrollment in the Phase 3 UTOPIA Clinical Trial of UGN-103 for the Treatment of Recurrent Low-Grade Intermediate-Risk Non-Muscle Invasive Bladder Cancer
PRINCETON, N.J., July 07, 2025 (GLOBE NEWSWIRE) -- UroGen Pharma Ltd. (Nasdaq:…
Aeries Technology Announces Completion of Fiscal Year 2025 Earnings Call
Core Adjusted EBITDA exceeds guidance; Company re-affirms FY 2026 outlook as AI-Centric…
Belite Bio Announces Completion of Enrollment in the Pivotal Global Phase 3 PHOENIX Trial Evaluating Oral Tinlarebant in Geographic Atrophy
July 02, 2025 03:00 ET | Source: Belite Bio, Inc - 500…
Gastops and Leeway Marine Advance Innovative Engine Oil Monitoring System with Successful Field Testing
DARTMOUTH, NS, May 26, 2025 /PRNewswire/ -- Gastops is pleased to announce…
2nd Edition of French Space Days Concludes Across India, Reinforcing Indo-French Space Collaboration
NEW DELHI, May 26, 2025 /PRNewswire/ -- Business France India is pleased…
Halia Therapeutics Completes Enrollment in Phase 2a Clinical Trial of HT-6184 for Myelodysplastic Syndrome (MDS)
LEHI, Utah, June 4, 2025 /PRNewswire/ -- Halia Therapeutics, a clinical-stage biopharmaceutical…
Acclaro Medical Raises $23 Million in Series B Funding Led by Accelmed Partners to Advance Groundbreaking 2910 nm Fiber Laser Technology
Accelmed $20 Million Investment with 3E Bioventures Capital Funding of $3 Million…
